174 related articles for article (PubMed ID: 33708616)
21. Predictors for Adherence to Treatment Strategies in Elderly HNSCC Patients.
Graessle R; Stromberger C; Heiland M; Doll C; Hofmann VM; Klinghammer K; Tinhofer I; Olze H; Beck M; Arens P; Dommerich S; Piwonski I; Coordes A
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053585
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy.
Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Gamez ME; Lukens JN; Shourbaji RA; Ryniak M; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
Anticancer Res; 2013 Dec; 33(12):5511-6. PubMed ID: 24324090
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis.
Walter F; Böckle D; Schmidt-Hegemann NS; Köpple R; Gerum S; Boeck S; Angele M; Belka C; Roeder F
Radiat Oncol; 2018 May; 13(1):93. PubMed ID: 29769143
[TBL] [Abstract][Full Text] [Related]
24. Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.
Fan D; Kang JJ; Fan M; Wang H; Lee A; Yu Y; Chen L; Jillian Tsai C; McBride SM; Riaz N; Gelblum DY; Neal BP; Fetten J; Dunn LA; Michel LS; Boyle JO; Cohen MA; Roman BR; Ganly I; Singh B; Wong RJ; Sherman EJ; Lee NY
Oral Oncol; 2020 May; 104():104641. PubMed ID: 32182548
[TBL] [Abstract][Full Text] [Related]
25. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
26. Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
Chou WC; Chang PH; Chen PT; Wang HM; Yeh KY; Lu CH; Hung YS; Tung-Chieh Chang J; Tsang NM; Ho YW; Chen SY; Lee SH; Hung CY; Wang LJ; Liao KC; Lin CH; Tang WR; Lin YC
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):602-611. PubMed ID: 31987971
[TBL] [Abstract][Full Text] [Related]
27. Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer.
Herman LC; Chen L; Garnett A; Feldman LE; Smith B; Weichselbaum RR; Spiotto MT
Oral Oncol; 2014 Jan; 50(1):52-8. PubMed ID: 24055193
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
30. Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes.
Chang JH; Wu CC; Yuan KS; Wu ATH; Wu SY
Oncotarget; 2017 Aug; 8(33):55600-55612. PubMed ID: 28903447
[TBL] [Abstract][Full Text] [Related]
31. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
[TBL] [Abstract][Full Text] [Related]
33. Associations Between Race and Survival Outcomes Among Veterans With Head and Neck Cancer in a Racially Diverse Setting.
Walsh AR; Giurintano JP; Maxwell JH; Shah AH; Haupt TL; Wadley AE; Kowkuntla SR; Habib AM; Shah V
OTO Open; 2024; 8(2):e150. PubMed ID: 38863487
[TBL] [Abstract][Full Text] [Related]
34. Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy.
Liu CT; Chiu TJ; Huang TL; Chien CY; Fang FM
Chang Gung Med J; 2010; 33(3):283-91. PubMed ID: 20584506
[TBL] [Abstract][Full Text] [Related]
35. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.
Firat S; Byhardt RW; Gore E
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):357-64. PubMed ID: 12243808
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery.
Flannery TW; Suntharalingam M; Regine WF; Chin LS; Krasna MJ; Shehata MK; Edelman MJ; Kremer M; Patchell RA; Kwok Y
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):19-23. PubMed ID: 18280058
[TBL] [Abstract][Full Text] [Related]
37. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
38. Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patients.
Han HR; Hermann GM; Ma SJ; Iovoli AJ; Wooten KE; Arshad H; Gupta V; McSpadden RP; Kuriakose MA; Markiewicz MR; Chan JM; Platek ME; Ray AD; Gu F; Hicks WL; Repasky EA; Singh AK
Oral Oncol; 2020 Jun; 109():104854. PubMed ID: 32559724
[TBL] [Abstract][Full Text] [Related]
39. Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients.
Iacovelli NA; Cicchetti A; Cavallo A; Alfieri S; Locati L; Ivaldi E; Ingargiola R; Romanello DA; Bossi P; Cavalieri S; Tenconi C; Meroni S; Calareso G; Guzzo M; Piazza C; Licitra L; Pignoli E; Carlo F; Orlandi E
Front Oncol; 2020; 10():518110. PubMed ID: 33072562
[No Abstract] [Full Text] [Related]
40. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]